■ Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening
R A Smith, K S Andrews, D Brooks et al
CA: A Cancer Journal for Clinicians 2017, vol 67 (2): 100-121
http://onlinelibrary.wiley.com/doi/10.3322/caac.21392/full
■ Rastreamento do câncer de próstata com PSA
Sadi, Marcus V.
Rev. Assoc. Med. Bras., Aug 2017, vol.63, no.8, p.722-725
■ New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
Wroclawski, Marcelo Langer.
Einstein (São Paulo), Sept 2017, vol.15, no.3, p.7-10
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082017000300007&lng=pt&nrm=iso
■ Metastatic prostate cancer in the modern era of PSA screening.
Fontenot Jr, Philip A. et al.
Int. braz j urol., June 2017, vol.43, no.3, p.416-421
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300416&lng=en&nrm=iso
■ Prostate cancer in Brazil and Latin America: epidemiology and screening
Tourinho-Barbosa, Rafael Rocha, Pompeo, Antonio Carlos Lima and Glina, Sidney
Int. braz j urol., Dec 2016, vol.42, no.6, p.1081-1090
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601081&lng=en&nrm=iso
■ Prostate cancer screening in Brazil: should it be done or not?.
Busato Jr., Wilson F. S. and Almeida, Gilberto L.
Int. braz j urol., Dec 2016, vol.42, no.6, p.1069-1080
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601069&lng=en&nrm=iso
■ Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
Aurora Perez-Cornago, Paul N. Appleby, Tobias Pischon et AL
BMC Med. 2017; 15: 115
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508687/
■ Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang, J. et al.
Braz J Med Biol Res, 2016, vol.49, no.8
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000800704&lng=en&nrm=iso
■ O papel da ecografia transretal no diagnóstico do câncer da próstata: novas contribuições
Lopes, Pedro Marinho et al.
Radiol Bras, Feb 2015, vol.48, no.1, p.7-11
■ Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para o rastreamento do câncer de mama.
Urban, Linei Augusta Brolini Dellê et al
Radiol Bras, Aug 2017, vol.50, no.4, p.244-249
■ Breast cancer screening in Brazil. Barriers related to the health system.
Vieira, René Aloisio da Costa, Formenton, Alessandro and Bertolini, Silvia Regina
Rev. Assoc. Med. Bras., May 2017, vol.63, no.5, p.466-474
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000500466&lng=pt&nrm=iso
■ Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement
A L Siu, on behalf of the U. S Preventive Service Task Force
Ann Intern Med 2016, vol 164 (4): 279-296
■ Rastreamento do câncer de mama em Minas Gerais: avaliação a partir de dados dos sistemas de informações do Sistema Único de Saúde.
Corrêa, Camila Soares Lima et al.
Epidemiol. Serv. Saúde, Set 2017, vol.26, no.3, p.481-492
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222017000300481&lng=pt&nrm=iso
■ Detecção precoce do câncer de mama no Brasil: dados da Pesquisa Nacional de Saúde, 2013
Silva, Gulnar Azevedo e et al
Rev. Saúde Pública, 2017, vol.51, suppl.1
■ What determines the effects and cost of breast cancer screening? A protocol of a systematic review of reviews
O Mandrik, O I Ekwunife, N Zielonke et al
Systematic Reviews2017, vol 6: 122
https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-017-0510-y
■ Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011
Stephen Morrell, Richard Taylor, David Roder et al
Br J Cancer. 2017 Mar 14; 116(6): 828–839
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355933/
■ Qualidade do rastreamento do câncer de colo uterino no Brasil: avaliação externa do PMAQ.
Barcelos, Mara Rejane Barroso et al
Rev. Saúde Pública, 2017, vol.51
■ Rastreamento do câncer do colo do útero em Teresina, Piauí: estudo avaliativo dos dados do Sistema de Informação do Câncer do Colo do Útero, 2006-2013
Damacena, Andressa Moura, Luz, Laércio Lima and Mattos, Inês Echenique
Epidemiol. Serv. Saúde, Mar 2017, vol.26, no.1, p.71-80
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222017000100071&lng=pt&nrm=iso
■ Regional and Socioeconomic Differences in the Coverage of the Papanicolau Test in Brazil: Data from the Brazilian Health Survey 2013.
Barbosa, Isabelle Ribeiro.
Rev. Bras. Ginecol. Obstet., Sept 2017, vol.39, no.9, p.480-487
■ Avaliação do rastreamento do cancer do colo do útero e sua periodicidade em um município de Santa Catarina
G B Trindade, S A Manenti, P W Simões, K Madeira
Medicina (Ribeirão Preto) 2017, vol 50 (1): 1-10
■ Rastreamento do câncer do colo do útero em Minas Gerais: avaliação a partir de dados do Sistema de Informação do Câncer do Colo do Útero (SISCOLO).
Corrêa, Camila Soares Lima et al.
Cad. saúde colet., Jul 2017, vol.25, no.3, p.315-323
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1414-462X2017000300315&lng=pt&nrm=iso
■ Avaliação das ações de detecção precoce do câncer de mama no Brasil por meio de indicadores de processo: estudo descritivo com dados do Sismama, 2010-2011
Tomazelli, Jeane Glaucia et al.
Epidemiol. Serv. Saúde, Mar 2017, vol.26, no.1, p.61-70
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222017000100061&lng=pt&nrm=iso
■ Organized, Population-based Cervical Cancer Screening Program: It Would Be a Good Time for Brazil Now.
Derchain, Sophie, Teixeira, Julio Cesar and Zeferino, Luiz Carlos
Rev. Bras. Ginecol. Obstet., Apr 2016, vol.38, no.4, p.161-16
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032016000400161&lng=en&nrm=iso
■ Predictive Capability of HPV and Pap Tests in Screening for Cervical Cancer over a Three-Year Follow-up
Girianelli, Vania Reis, Thuler, Luiz Claudio Santos and Silva, Gulnar Azevedo e
Rev. Bras. Ginecol. Obstet., Mar 2016, vol.38, no.3, p.147-153
■ Quality Indicators of Cervical Cytopathology Tests in the Public Service in Minas Gerais, Brazil
Tobias, Alessandra Hermógenes Gomes et al.
Rev. Bras. Ginecol. Obstet., Feb 2016, vol.38, no.2, p.65-70
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032016000200065&lng=en&nrm=iso
■ Comparación entre las técnicas de cribado de patología cervical y las conizaciones de tres hospitales en España
Lafalla Bernad, Olivia et al.
Rev. chil. obstet. ginecol., Jun 2017, vol.82, no.3, p.265-270
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262017000300265&lng=en&nrm=iso
■ A review of the current cervical cancer screening guidelines
A C Perkins
North Carolina Medical Journal 2016, vol 77 (6): 420-422
http://www.ncmedicaljournal.com/content/77/6/420.full
■ Review of the Brazilian Guidelines for Cervical Cancer Screening, 2016.
Katz, Leticia Maria C.
- Bras. Patol. Med. Lab., Sept 2016, vol.52, no.4, p.210-210
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000400210&lng=en&nrm=iso
■ Cervical cancer screening: from Pap smear to future strategies.
Mitteldorf, Cristina Aparecida T. S.
- Bras. Patol. Med. Lab., Sept 2016, vol.52, no.4, p.238-245
■ Anal cytology in women with cervical intraepithelial or invasive cancer: interobserver agreement.
Heráclio, Sandra A. et al.
- Bras. Patol. Med. Lab., Oct 2015, vol.51, no.5, p.315-322
■ Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study
Alejandra Castañón, Rebecca Landy, Jack Cuzick, Peter Sasieni
PLoS Med. 2014 Jan; 11(1): e1001585
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891624/
■ Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings
Nicole G. Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Jane J. Kim
Cancer Med. 2017 Aug; 6(8): 2008–2014.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548874/
■ Ovarian cancer screening and mortality in the UK Collaborative Trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial
I J Jacobs, U Menon, A Ryan et al
Lancet 2016, vol 387 (10022): 945-956
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779792/
■ United Kingdom Collaborative Trial of Ovarian Cancer Screening
U Menon, A Ryan, J Kalsi et al
Journal of Clinical Oncology jun 2015
http://ascopubs.org/doi/full/10.1200/JCO.2014.59.4945
■ Colorectal cancer screening
Recommendation for Physician and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer
D K Rex, C R Boland, J A Dominitz et al
Am J Gastroenterol june 2017
http://gi.org/wp-content/uploads/2017/06/ajg2017174a.pdf
■ Current evidence for universal molecular testing for colorectal cancer patients
Campos, Fábio Guilherme, Figueiredo, Marleny Novaes and Martinez, Carlos Augusto Real
- Coloproctol. (Rio J.), Sept 2017, vol.37, no.3, p.174-178
■ Adenoma detection rate evaluation and quality of colonoscopy in the center-west region of Brasil
Cardoso, Daniela Medeiros Milhomem, Botacin, Marco Aurélio Silveira and Mekdessi, Marilia Adriano
Arq. Gastroenterol., Dec 2017, vol.54, no.4, p.315-32
■ Octogenarian patients with colorectal cancer: characterizing an emerging clinical entity
Hadar Goldvaser, Noa Katz Shroitman, Irit Ben-Aharon et al
World J Gastroenterol. 2017 Feb 28; 23(8): 1387–1396
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330823/
■ Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients
V F Zumstein, F Vinzens, A Zett et al
Swiss Med Wkly 2016, vol 146: w14315
https://smw.ch/article/doi/smw.2016.14315/
■ Advances in fecal tests for colorectal cancer screening
E H Schreuders, E J Grobbee, M C W Spaander, E J Kuipers
Curr Treat Options Gastroenterol 2016, vol 14: 152-162
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783443/
■ Fecal occult blood test results of the National Colorectal Cancer Screening Program in South Korea (2006-2013)
J H Rim, T Youk, J G Kang et al
Scientific Reports 2017, vol 7, article number: 2804
https://www.nature.com/articles/s41598-017-03134-9
■ Colorectal cancer screening: stool DNA and other noninvasive modalities
James R. Bailey, Ashish Aggarwal, Thomas F. Imperiale
Gut Liver. 2016 Mar; 10(2): 204–211
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780449/
■ Do pathological variables have prognostic significance in recatal adenocarcinoma treated with neoadjuvant chmoradiotherapy and surgery?
Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Valeria Barresi
World J Gastroenterol. 2017 Feb 28; 23(8): 1412–1423
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330826/
■ Measurement of biological age may help to assess the risk of colorectal adenoma in screening colonoscopy
Sang-Jung Kim, Beom Jin Kim, Hyun Kang
World J Gastroenterol. 2017 Oct 7; 23(37): 6877–6883
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645620/
■ Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer
Renate S Olsen, Johnny Nijm, Roland E Andersson, Jan Dimberg, Dick Wågsäter
World J Gastroenterol. 2017 Sep 14; 23(34): 6212–6219
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603487/
■ Colorectal cancer, screening and primary care: a mini literature review
Athanasios Hadjipetrou, Dimitrios Anyfantakis, Christos G Galanakis et AL
World J Gastroenterol. 2017 Sep 7; 23(33): 6049–6058
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597496/
■ Colorectal câncer screening: na updated review of the available options
I A Issa, M Noureddine
World J Gastroenterol 2017, vol 23 (28): 5086-5096
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537177/
■ Colorectal cancer population screening programs worldwide in 2016: an update
Mercedes Navarro, Andrea Nicolas, Angel Ferrandez, Angel Lanas
World J Gastroenterol. 2017 May 28; 23(20): 3632–364
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449420/
■ Colorectal and interval cancers of the colorectal cancer screening program in the Basque Country (Spain)
Isabel Portillo, Eunate Arana-Arri, Isabel Idigoras et AL
World J Gastroenterol. 2017 Apr 21; 23(15): 2731–2742
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403752/
■ From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world
Dimitrios Dimitroulis, Christos Damaskos, Serena Valsami, et AL
World J Gastroenterol. 2017 Aug 7; 23(29): 5282–5294
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550777/
■ Genetic biomarkers for hepatocellular cancer risk in a Caucasian population
Elena De Mattia, Erika Cecchin, Jerry Polesel et al
World J Gastroenterol. 2017 Sep 28; 23(36): 6674–6684
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643288/
■ Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma
Carrilho, Flair J et al.
Arq. Gastroenterol., Dec 2015, vol.52, suppl.1, p.2-14
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032015000500002&lng=en&nrm=iso
■ Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma
Carrilho, Flair J et al.
Arq. Gastroenterol., Dec 2015, vol.52, suppl.1, p.2-14
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032015000500002&lng=en&nrm=iso
■ Pancreatic cancer screening
Soldan, Mônica
Rev. Col. Bras. Cir., Apr 2017, vol.44, no.2, p.109-111
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912017000200109&lng=en&nrm=iso
■ Is endobronchial ultrasound-guided transbronchial needle aspiration with a stylet necessary for lymph node screening in lung cancer patients?
Xu, Y. et al.
Braz J Med Biol Res, 2017, vol.50, no.10
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017001000606&lng=en&nrm=iso
■ Lung cancer screening
L T Tanoue, N T Tanner, M K Gould, G A Silvestri
AJRCCM 2015, vol 191(1)
http://www.atsjournals.org/doi/full/10.1164/rccm.201410-1777CI
■ American Cancer Society lung cancer screening guidelines
Richard Wender, Elizabeth T. H. Fontham, Ermilo Barrera et al
CA Cancer J Clin. 2013 Mar-Apr; 63(2): 107–117
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632634/
■ Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population
Adonis, Marta I et al.
Biol. Res., 2014, vol.47, p.1-9
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602014000100056&lng=en&nrm=iso
■ Computed tomography screening for lung cancer: Has it finally arrived? Implications of the National Lung Screening Trial
D R Aberle, F Abtin, K Brown
Journal of Clinical Oncology mar 2013
http://ascopubs.org/doi/full/10.1200/JCO.2012.43.3110
■ Screening and early detection of lung cancer
S C van´t Westeinde, R J van Klaveren
The Cancer Journal 2011, vol 17 (1): 3-10
■ Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
Jasper Wouters, Miguel Vizoso, Anna Martinez-Cardus et al
BMC Med. 2017; 15: 101
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458482/
■ Head and neck squamours cell carcinoma: update on epidemiology, diagnosis, and treatment
S Marur, A A Forastiere
Mayo Clinic Proceedings 2016: 386-396
http://www.mayoclinicproceedings.org/article/S0025-6196(15)01006-X/fulltext
■ What do Cochrane systematic reviews say about the clinical effectiveness of screening and diagnostic tests for cancer?
Bueno, André Tito Pereira et al.
Sao Paulo Med. J., Aug 2017, vol.135, no.4, p.401-410
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802017000400401&lng=en&nrm=iso
■ Screening for cancer: advice for high-value care from the American College of Physician
T J Wilt, R P Harris, A Qaseem et al
Ann Intern Med 2015, vol 162 (10): 718-725
■ The ACA and cancer screening and diagnosis
L M Sabik, G Adunlin
The Cancer Journal 2017, vol 23 (3): 151-162
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com